ATE420103T1 - Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen - Google Patents

Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen

Info

Publication number
ATE420103T1
ATE420103T1 AT01972382T AT01972382T ATE420103T1 AT E420103 T1 ATE420103 T1 AT E420103T1 AT 01972382 T AT01972382 T AT 01972382T AT 01972382 T AT01972382 T AT 01972382T AT E420103 T1 ATE420103 T1 AT E420103T1
Authority
AT
Austria
Prior art keywords
hiv
inhibitors
treating
infections caused
replication
Prior art date
Application number
AT01972382T
Other languages
English (en)
Inventor
Christian Devaux
Veronique Hebmann
Gilles Divita
Frederic Heitz
Catherine Morris
Jean Mery
Roger Goody
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE420103T1 publication Critical patent/ATE420103T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01972382T 2000-08-25 2001-08-21 Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen ATE420103T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/648,557 US7790171B1 (en) 2000-08-25 2000-08-25 Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase

Publications (1)

Publication Number Publication Date
ATE420103T1 true ATE420103T1 (de) 2009-01-15

Family

ID=24601279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972382T ATE420103T1 (de) 2000-08-25 2001-08-21 Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen

Country Status (6)

Country Link
US (2) US7790171B1 (de)
EP (1) EP1311538B1 (de)
AT (1) ATE420103T1 (de)
AU (1) AU2001292153A1 (de)
DE (1) DE60137340D1 (de)
WO (1) WO2002015661A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010201A2 (en) * 2000-07-31 2002-02-07 Active Motif Peptide-mediated delivery of molecules into cells
AU2003233310A1 (en) * 2002-05-08 2003-11-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Agent and method for transporting biologically active molecules in cells
EP2174948A1 (de) * 2008-09-26 2010-04-14 Centre National De La Recherche Scientifique Antivirale Polypeptide
JP2012146377A (ja) * 2011-01-14 2012-08-02 Elpida Memory Inc 半導体装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
AU1075001A (en) 1999-10-05 2001-05-10 Epimmune, Inc. Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
WO2002010201A2 (en) 2000-07-31 2002-02-07 Active Motif Peptide-mediated delivery of molecules into cells

Also Published As

Publication number Publication date
WO2002015661A2 (en) 2002-02-28
US7790171B1 (en) 2010-09-07
US20110064793A1 (en) 2011-03-17
WO2002015661A3 (en) 2003-01-23
AU2001292153A1 (en) 2002-03-04
EP1311538B1 (de) 2009-01-07
WO2002015661A8 (en) 2002-11-14
EP1311538A2 (de) 2003-05-21
DE60137340D1 (de) 2009-02-26

Similar Documents

Publication Publication Date Title
HUP0301842A2 (hu) Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására
HUP0000492A1 (hu) N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával
SE0002202D0 (sv) New peptides
ES2170239T3 (es) Peptidos antifungicos de d-aminoacidos basados en histatina.
NO974147D0 (no) Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
WO2005002500A3 (en) Inhibitors of coronavirus
ATE420103T1 (de) Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE60131085D1 (de) Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika
DE69330268T2 (de) Hämoregulierende peptide
HUP0301523A2 (hu) VEGF-peptidek és alkalmazásuk angiogenezis gátlására
DE60227665D1 (de) Tsg101 als inhibitor der hiv-produktion
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
HUP0303181A2 (hu) 4-Foszfodiészteráz típusú inhibitorok alkalmazása miokardiális betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
UA91497C2 (ru) ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА
ATE285244T1 (de) Tripeptide und deren derivate zur behandlung von postläsionalen krankheiten des nervensystems
ATE46173T1 (de) Pharmakologisch aktive peptide.
ATE297720T1 (de) Campher wässrige lösung zur behandlung degenerativer und autoimmuner erkrankungen sowie als immunomodulator
DE50210473D1 (de) Phosphinat-peptidanaloga als inhibitoren der procollagen-c-proteinase (pcp) zur behandlung von fibrotischen erkrankungen
DE60034580D1 (de) Peptid zur behandlung von nervenerkrankungen
ATE310529T1 (de) Tripeptidderivate zur behandlung von postläsionalen krankheiten des nervensystems
ATE321551T1 (de) Methoden zur behandlung des kryptorchysmus
ATE386524T1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties